Report cover image

Middle East Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids), By Technology (PCR, NGS), By Application (Healthcare, Non-healthcare), By End Use, By Country, And Segment Forec

Publisher Grand View Research
Published Nov 04, 2025
Length 150 Pages
SKU # GV20649470

Description

Middle East Synthetic Biology Market Summary

The Middle East synthetic biology market size was estimated at USD 223.3 million in 2024 and is expected to reach USD 705.2 million by 2033, growing at a CAGR of 13.47% from 2025 to 2033, Growing biotechnology investments, demand for novel treatments, and encouraging government programs to develop the area's synthetic biology capabilities are the main drivers of this expansion.

Middle East Synthetic Biology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East synthetic biology market on the basis of product, technology, application end use, and country:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Other Technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Healthcare
  • Clinical
  • Bio/Pharmaceuticals
  • Diagnostics
  • Non-Clinical
  • Non-healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-fuels
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biotechnology and Pharmaceutical companies
  • Academic and Research Institutes
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
  • Rest of Middle East
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information Analysis
1.3.1. Market Formulation & Data Visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Dynamics
3.2.1.1. Technical Advancements
3.2.1.2. Academic & Research Expansion
3.2.2. Market Restraint Analysis
3.2.2.1. Biosafety and Biosecurity Issue
3.2.2.2. Ethical Issues and Unintended Consequences
3.3. Industry Analysis Tools
3.3.1. PESTLE Analysis
3.3.2. Porter’s Five Forces Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Middle East Synthetic Biology Market: Product Movement Analysis
4.3. Middle East Synthetic Biology Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Oligonucleotide/Oligo pools and Synthetic DNA
4.4.1. Oligonucleotide/Oligo pools and Synthetic DNA Market, 2021 - 2033 (USD Million)
4.5. Enzymes
4.5.1. Enzymes Market, 2021 - 2033 (USD Million)
4.6. Cloning Technologies Kits
4.6.1. Cloning Technologies Kits Market, 2021 - 2033 (USD Million)
4.7. Xeno-nucleic Acids
4.7.1. Xeno-nucleic Acids Market, 2021 - 2033 (USD Million)
4.8. Chassis Organism
4.8.1. Chassis Organism Market, 2021 - 2033 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Technology Segment Dashboard
5.2. Middle East Synthetic Biology Market: Technology Movement Analysis
5.3. Middle East Synthetic Biology Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. PCR
5.4.1. PCR Market, 2021 - 2033 (USD Million)
5.5. Genome Editing
5.5.1. Genome Editing Market, 2021 - 2033 (USD Million)
5.6. NGS
5.6.1. NGS Market, 2021 - 2033 (USD Million)
5.7. Bioprocessing Technology
5.7.1. Bioprocessing Technology Market, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Application Segment Dashboard
6.2. Middle East Synthetic Biology Market: Application Movement Analysis
6.3. Middle East Synthetic Biology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Synthetic Biology Market: Technology Movement Analysis
6.5. Healthcare
6.5.1. Healthcare Market, 2021 - 2033 (USD Million)
6.5.2. Clinical
6.5.2.1. Clinical Market, 2021 - 2033 (USD Million)
6.5.2.2. Bio/Pharmaceuticals
6.5.2.2.1. Bio/Pharmaceuticals Market, 2021 - 2033 (USD Million)
6.5.2.3. Diagnostics
6.5.2.3.1. Diagnostics Market, 2021 - 2033 (USD Million)
6.5.3. Non-Clinical
6.5.3.1. Non-Clinical Market, 2021 - 2033 (USD Million)
6.6. Non-Healthcare
6.6.1. Non-Healthcare Market, 2021 - 2033 (USD Million)
6.6.2. Biotech Crops
6.6.2.1. Biotech Crops Market, 2021 - 2033 (USD Million)
6.6.3. Specialty Chemicals
6.6.3.1. Specialty Chemicals Market, 2021 - 2033 (USD Million)
6.6.4. Bio-Fuels
6.6.4.1. Bio-Fuels Market, 2021 - 2033 (USD Million)
6.6.5. Others
6.6.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. End Use Segment Dashboard
7.2. Middle East Synthetic Biology Market: End Use Movement Analysis
7.3. Middle East Synthetic Biology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Biotechnology and Pharmaceutical Companies
7.4.1. Biotechnology and Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 8. Country Business Analysis
8.1. Country Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. Middle East
8.3.1. Middle East Synthetic Biology Market, 2021 - 2033 (USD Million)
8.3.2. Qatar
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Qatar Synthetic Biology Market, 2021 - 2033 (USD Million)
8.3.3. Saudi Arabia
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Saudi Arabia Synthetic Biology Market, 2021 - 2033 (USD Million)
8.3.4. UAE
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. UAE Synthetic Biology Market, 2021 - 2033 (USD Million)
8.3.5. Kuwait
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Kuwait Synthetic Biology Market, 2021 - 2033 (USD Million)
8.3.6. Oman
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Oman Synthetic Biology Market, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Participant’s Overview
9.4.1. Bota Biosciences Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Codexis, Inc.
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Creative Biogene
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Creative Enzymes
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Enbiotix, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Illumina, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Merck KGaA
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. New England Biolabs
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Eurofins Scientific
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Novozymes
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Pareto Bio, Inc.
9.4.11.1. Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Scarab Genomics, Inc.
9.4.12.1. Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. Synthego
9.4.13.1. Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. Synthetic Genomics Inc.
9.4.14.1. Overview
9.4.14.2. Financial Performance
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Thermo Fisher Scientific, Inc.
9.4.15.1. Overview
9.4.15.2. Financial Performance
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us